Probiotic Lactobacillus gasseri SBT2055 improves insulin secretion in a diabetic rat model

M. Niibo, Bungo Shirouchi, M. Umegatani, Y. Morita, A. Ogawa, F. Sakai, Y. Kadooka, Masao Sato

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The probiotic Lactobacillus gasseri SBT2055 (LG2055) has a protective effect against metabolic syndrome in rats and humans. Metabolic syndrome increases the risk of type 2 diabetes mellitus. In this study, Goto-Kakizaki rats were used as a diabetic model and fed diets containing LG2055-fermented or nonfermented skim milk for 4 wk. Indices of diabetes such as blood glucose levels, serum glucagon levels, plasma levels of insulin, C-peptide, and glucagon-like peptide-1, tissue glycogen contents, and pancreatic mRNA levels were measured. The plasma C-peptide levels and pancreatic mRNA levels of insulin genes (Ins1 and Ins2) and Pdx1 (a transcriptional factor of insulin genes) were increased in LG2055 diet-fed rats. The increase in insulin secretion corresponded to an improvement in serum and pancreatic inflammatory status, associated with decreases in serum levels of serum amyloid P and pancreatic levels of granulocyte colony-stimulating factor. Insulin resistance in Goto-Kakizaki rats was ameliorated by increased glycogen storage in the liver and quadriceps femoris muscles and decreased serum free fatty acid levels. This improvement may be related to the increased cecal production of short-chain fatty acids. In conclusion, dietary LG2055 improved insulin secretion in diabetic rats by improving the inflammatory status in the pancreas and serum.

Original languageEnglish
Pages (from-to)997-1006
Number of pages10
JournalJournal of Dairy Science
Volume102
Issue number2
DOIs
Publication statusPublished - Feb 1 2019

Fingerprint

Lactobacillus gasseri
insulin secretion
Probiotics
probiotics
animal models
Insulin
rats
Serum
insulin
metabolic syndrome
C-Peptide
Quadriceps Muscle
glycogen
Glycogen
peptides
granulocyte colony-stimulating factor
glucagon-like peptide 1
Diet
glucagon
short chain fatty acids

All Science Journal Classification (ASJC) codes

  • Food Science
  • Animal Science and Zoology
  • Genetics

Cite this

Probiotic Lactobacillus gasseri SBT2055 improves insulin secretion in a diabetic rat model. / Niibo, M.; Shirouchi, Bungo; Umegatani, M.; Morita, Y.; Ogawa, A.; Sakai, F.; Kadooka, Y.; Sato, Masao.

In: Journal of Dairy Science, Vol. 102, No. 2, 01.02.2019, p. 997-1006.

Research output: Contribution to journalArticle

Niibo, M. ; Shirouchi, Bungo ; Umegatani, M. ; Morita, Y. ; Ogawa, A. ; Sakai, F. ; Kadooka, Y. ; Sato, Masao. / Probiotic Lactobacillus gasseri SBT2055 improves insulin secretion in a diabetic rat model. In: Journal of Dairy Science. 2019 ; Vol. 102, No. 2. pp. 997-1006.
@article{4534bbc5dea34a26890e656952e8d29a,
title = "Probiotic Lactobacillus gasseri SBT2055 improves insulin secretion in a diabetic rat model",
abstract = "The probiotic Lactobacillus gasseri SBT2055 (LG2055) has a protective effect against metabolic syndrome in rats and humans. Metabolic syndrome increases the risk of type 2 diabetes mellitus. In this study, Goto-Kakizaki rats were used as a diabetic model and fed diets containing LG2055-fermented or nonfermented skim milk for 4 wk. Indices of diabetes such as blood glucose levels, serum glucagon levels, plasma levels of insulin, C-peptide, and glucagon-like peptide-1, tissue glycogen contents, and pancreatic mRNA levels were measured. The plasma C-peptide levels and pancreatic mRNA levels of insulin genes (Ins1 and Ins2) and Pdx1 (a transcriptional factor of insulin genes) were increased in LG2055 diet-fed rats. The increase in insulin secretion corresponded to an improvement in serum and pancreatic inflammatory status, associated with decreases in serum levels of serum amyloid P and pancreatic levels of granulocyte colony-stimulating factor. Insulin resistance in Goto-Kakizaki rats was ameliorated by increased glycogen storage in the liver and quadriceps femoris muscles and decreased serum free fatty acid levels. This improvement may be related to the increased cecal production of short-chain fatty acids. In conclusion, dietary LG2055 improved insulin secretion in diabetic rats by improving the inflammatory status in the pancreas and serum.",
author = "M. Niibo and Bungo Shirouchi and M. Umegatani and Y. Morita and A. Ogawa and F. Sakai and Y. Kadooka and Masao Sato",
year = "2019",
month = "2",
day = "1",
doi = "10.3168/jds.2018-15203",
language = "English",
volume = "102",
pages = "997--1006",
journal = "Journal of Dairy Science",
issn = "0022-0302",
publisher = "Elsevier Limited",
number = "2",

}

TY - JOUR

T1 - Probiotic Lactobacillus gasseri SBT2055 improves insulin secretion in a diabetic rat model

AU - Niibo, M.

AU - Shirouchi, Bungo

AU - Umegatani, M.

AU - Morita, Y.

AU - Ogawa, A.

AU - Sakai, F.

AU - Kadooka, Y.

AU - Sato, Masao

PY - 2019/2/1

Y1 - 2019/2/1

N2 - The probiotic Lactobacillus gasseri SBT2055 (LG2055) has a protective effect against metabolic syndrome in rats and humans. Metabolic syndrome increases the risk of type 2 diabetes mellitus. In this study, Goto-Kakizaki rats were used as a diabetic model and fed diets containing LG2055-fermented or nonfermented skim milk for 4 wk. Indices of diabetes such as blood glucose levels, serum glucagon levels, plasma levels of insulin, C-peptide, and glucagon-like peptide-1, tissue glycogen contents, and pancreatic mRNA levels were measured. The plasma C-peptide levels and pancreatic mRNA levels of insulin genes (Ins1 and Ins2) and Pdx1 (a transcriptional factor of insulin genes) were increased in LG2055 diet-fed rats. The increase in insulin secretion corresponded to an improvement in serum and pancreatic inflammatory status, associated with decreases in serum levels of serum amyloid P and pancreatic levels of granulocyte colony-stimulating factor. Insulin resistance in Goto-Kakizaki rats was ameliorated by increased glycogen storage in the liver and quadriceps femoris muscles and decreased serum free fatty acid levels. This improvement may be related to the increased cecal production of short-chain fatty acids. In conclusion, dietary LG2055 improved insulin secretion in diabetic rats by improving the inflammatory status in the pancreas and serum.

AB - The probiotic Lactobacillus gasseri SBT2055 (LG2055) has a protective effect against metabolic syndrome in rats and humans. Metabolic syndrome increases the risk of type 2 diabetes mellitus. In this study, Goto-Kakizaki rats were used as a diabetic model and fed diets containing LG2055-fermented or nonfermented skim milk for 4 wk. Indices of diabetes such as blood glucose levels, serum glucagon levels, plasma levels of insulin, C-peptide, and glucagon-like peptide-1, tissue glycogen contents, and pancreatic mRNA levels were measured. The plasma C-peptide levels and pancreatic mRNA levels of insulin genes (Ins1 and Ins2) and Pdx1 (a transcriptional factor of insulin genes) were increased in LG2055 diet-fed rats. The increase in insulin secretion corresponded to an improvement in serum and pancreatic inflammatory status, associated with decreases in serum levels of serum amyloid P and pancreatic levels of granulocyte colony-stimulating factor. Insulin resistance in Goto-Kakizaki rats was ameliorated by increased glycogen storage in the liver and quadriceps femoris muscles and decreased serum free fatty acid levels. This improvement may be related to the increased cecal production of short-chain fatty acids. In conclusion, dietary LG2055 improved insulin secretion in diabetic rats by improving the inflammatory status in the pancreas and serum.

UR - http://www.scopus.com/inward/record.url?scp=85056845920&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056845920&partnerID=8YFLogxK

U2 - 10.3168/jds.2018-15203

DO - 10.3168/jds.2018-15203

M3 - Article

C2 - 30471910

AN - SCOPUS:85056845920

VL - 102

SP - 997

EP - 1006

JO - Journal of Dairy Science

JF - Journal of Dairy Science

SN - 0022-0302

IS - 2

ER -